NasdaqCM - Delayed Quote USD

AVITA Medical, Inc. (RCEL)

8.52 +0.22 (+2.65%)
At close: April 26 at 4:00 PM EDT
8.52 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
6/30/2021
6/30/2020
Total Revenue
50,143.00
50,143.00
34,421.00
29,232.00
14,263.00
Cost of Revenue
7,780.00
7,780.00
6,041.00
5,949.00
2,973.00
Gross Profit
42,363.00
42,363.00
28,380.00
23,283.00
11,290.00
Operating Expense
85,018.00
85,018.00
55,885.00
49,823.00
53,969.00
Operating Income
-42,655.00
-42,655.00
-27,505.00
-26,540.00
-42,679.00
Net Non Operating Interest Income Expense
-1,143.00
-1,143.00
-16.00
-22.00
-33.00
Other Income Expense
8,483.00
8,483.00
892.00
17.00
686.00
Pretax Income
-35,315.00
-35,315.00
-26,629.00
-26,545.00
-42,026.00
Tax Provision
66.00
66.00
36.00
38.00
4.00
Net Income Common Stockholders
-35,381.00
-35,381.00
-26,665.00
-26,583.00
-42,030.00
Diluted NI Available to Com Stockholders
-35,381.00
-35,381.00
-26,665.00
-26,583.00
-42,030.00
Basic EPS
-1.40
--
-1.07
-1.17
-2.07
Diluted EPS
-1.40
--
-1.07
-1.17
-2.07
Basic Average Shares
25,000.18
--
25,000.18
22,674.31
20,290.97
Diluted Average Shares
25,331.26
--
25,000.18
22,674.31
20,290.97
Total Operating Income as Reported
-42,655.00
-42,655.00
-27,505.00
-26,540.00
-42,679.00
Total Expenses
92,798.00
92,798.00
61,926.00
55,772.00
56,942.00
Net Income from Continuing & Discontinued Operation
-35,381.00
-35,381.00
-26,665.00
-26,583.00
-42,030.00
Normalized Income
-35,381.00
-35,381.00
-26,665.00
-26,583.00
-42,030.00
Interest Expense
1,143.00
1,143.00
16.00
22.00
33.00
Net Interest Income
-1,143.00
-1,143.00
-16.00
-22.00
-33.00
EBIT
-34,172.00
-34,172.00
-26,613.00
-26,523.00
-41,993.00
EBITDA
-33,540.00
-33,540.00
-26,045.00
-25,808.00
-41,528.00
Reconciled Cost of Revenue
7,780.00
7,780.00
6,041.00
5,949.00
2,973.00
Reconciled Depreciation
632.00
632.00
568.00
715.00
465.00
Net Income from Continuing Operation Net Minority Interest
-35,381.00
-35,381.00
-26,665.00
-26,583.00
-42,030.00
Normalized EBITDA
-33,540.00
-33,540.00
-26,045.00
-25,808.00
-41,528.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
6/30/2020 - 5/14/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TELA TELA Bio, Inc.
4.4500
+1.37%
 
CVRX CVRx, Inc.
14.69
+2.08%
 
CTSO Cytosorbents Corporation
0.8190
+1.24%
 
SILK Silk Road Medical, Inc
17.80
+0.85%
 
CERS Cerus Corporation
1.7100
+0.59%
 
PNV.AX PolyNovo Limited
1.9900
-4.78%
 
MYO Myomo, Inc.
3.4300
+0.29%
 
KIDS OrthoPediatrics Corp.
30.26
+1.07%
 
CNMD CONMED Corporation
65.78
+6.27%
 
IART Integra LifeSciences Holdings Corporation
28.34
-0.25%